Chennai:
The first U.S. patent was granted for a medicine to treat multiple sclerosis, a disease that affects the body’s nervous system. This is a comforting discovery for those suffering from Multiple Sclerosis (MS) worldwide.
The second U.S. patent is for developing the world’s first multimodal nano-contrast agent that can provide improved image resolution in X-rays, MRIs, and infrared fluorescence. It is an effective and innovative discovery for both detection and treatment of cancer.
A third U.S. patent has been obtained for a nanotextile-based small-diameter blood vessel graft which lasts longer without occlusion during use. It has been successfully tested in rabbits and pigs. The next step will be testing in humans.
An Indian patent was obtained for the invention of a core-shell nanoparticle system that could deliver multiple drugs simultaneously and target them to the disease efficiently without causing toxicity. Many cancers require multiple drug administration which can otherwise be very toxic.
An Indian patent was obtained for the development of a new type of surface-nanostructured orthopaedic and dental implant which integrates very well to surrounding normal bone. It improves implant life.
The last Indian patent was obtained for the invention of a new surface-modified stent that prevents blockage of the vessel after implant. Current stents elute drugs to prevent blockage but this stent does not require any drugs.
The research behind these discoveries were led by Dr. Shanti Kumar V. Nair, Director of Amrita Center for Nanoscience and Molecular Medicine, Dr. Manzoor Koyakutty, Dr. Deepthy Menon, Dr Praveen Verma, Dr Krishnakumar Menon, Dr Gopi Mohan, Dr. Anusha Ashokan, and Dr. Vijay Harish.
